183 related articles for article (PubMed ID: 8827085)
1. Clinical study on estramustine binding protein (EMBP) in human prostate.
Shiina H; Igawa M; Ishibe T
Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
[TBL] [Abstract][Full Text] [Related]
2. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
Shiina H; Igawa M; Ishibe T
Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
[TBL] [Abstract][Full Text] [Related]
3. Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate.
Shiina H; Urakami S; Shirakawa H; Igawa M; Ishibe T; Usui T
Eur Urol; 1996; 29(1):106-10. PubMed ID: 8821700
[TBL] [Abstract][Full Text] [Related]
4. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue.
Shiina H; Sumi H; Ishibe T; Usui T
Urol Int; 1994; 52(4):213-6. PubMed ID: 8030169
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T
Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957
[TBL] [Abstract][Full Text] [Related]
8. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
Björk PA; Flüchter SH; Nelde HJ
Scand J Urol Nephrol Suppl; 1988; 107():59-64. PubMed ID: 3287599
[TBL] [Abstract][Full Text] [Related]
9. Estramustine binding protein in human benign prostatic hypertrophy.
Shiina H; Mizutani M; Ishibe T
Andrologia; 1990; 22(4):309-12. PubMed ID: 1702270
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
[TBL] [Abstract][Full Text] [Related]
11. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
12. Relationship of thyroid to estramustine binding protein (EMBP) concentration in rat prostate.
Shiina H; Sumi H; Ishibe T; Usui T
Andrologia; 1991; 23(2):145-9. PubMed ID: 1952120
[TBL] [Abstract][Full Text] [Related]
13. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study.
Flüchter SH; Nelde HJ; Björk P; Müntzing J; Bichler KH
Prostate; 1989; 14(1):27-43. PubMed ID: 2648345
[TBL] [Abstract][Full Text] [Related]
14. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
[TBL] [Abstract][Full Text] [Related]
15. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
16. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R
Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia.
de la Torre M; Eklöv S; Häggman M; Björk P; Busch C; Nilsson S
Prostate; 1994 Sep; 25(3):125-31. PubMed ID: 7520576
[TBL] [Abstract][Full Text] [Related]
18. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA.
Shiina H; Ishibe T; Usui T
Biochem Biophys Res Commun; 1989 Dec; 165(3):947-55. PubMed ID: 2482024
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
Dulińska J; Laidler P; Labedź M
Acta Biochim Pol; 2002; 49(2):357-68. PubMed ID: 12362977
[TBL] [Abstract][Full Text] [Related]
20. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
